Doxepin
3-(6H-Benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine
Drag to rotate. Structure from PubChem CID 3158.
Background
Listing
- Schedules
- Schedule 4 to 5, conditions apply
- Source
- Consolidated Schedules 06 July 2026
Registered medicines
1 registered product listed
Counted through the register's ingredient index, which does not reach every record.
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Doxepin | Sinequan | Not stated | Pfizer Laboratories (Pty) Ltd | 2 registrations | S4 to S5conditions apply |
Regulatory status
Where S4 to S5 sits on the scale
Depends on which listing applies
At the least restrictive, Schedule 4: prescription-only medicine. At the most restrictive, Schedule 5: prescription-only, with tighter controls on repeats. The listings below say which applies to which form, strength or pack size.
Schedule S4 to S5, as the Consolidated Schedules list it.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.
Consolidated Schedules listings for Doxepin
S5: Doxepin
- except when intended for application to the skin.
Consolidated Schedules 06 July 2026, line 9395
S4: Doxepin
- when intended for application to the skin.
Consolidated Schedules 06 July 2026, line 6114
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.